文献速递头颈部肿瘤放疗中枢神经肿瘤放疗放疗物理与技术

鼻咽癌放射性脑损伤综合预测模型用于风险分层与个体化放疗

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma.
PubMed 文献 · Radiother Oncol · 2023-10-31

基于1189例接受调强放疗的鼻咽癌患者回顾性注册研究,建立包含38个SNP的多基因风险评分(PRS)及结合临床因素的列线图预测放射性脑损伤。PRS可有效识别高风险个体(P=1.42×10⁻³⁴),并据此提出颞叶耐受剂量方案;PRS联合临床因素使预测C指数从0.78提升至0.85(P=1.63×10⁻²)。

要点

  • 38-SNP PRS可有效识别放射性脑损伤高风险个体(P=1.42×10⁻³⁴)。
  • 推荐颞叶耐受剂量:PRS前10%亚组为57.6 Gy,后50%亚组为68.1 Gy。
  • 高遗传风险且颞叶D0.5CC>65 Gy者风险约为低PRS低剂量者的50倍(HR=50.09)。

核心结论

  • PRS联合临床因素可改善放射性脑损伤风险分层,并提示个体化放疗。

研究设计与样本

  • 基于注册登记的大规模回顾性研究,对1189例接受调强放疗的鼻咽癌患者进行磁共振成像随访观察放射性脑损伤发生,开展全基因组关联研究并建立多基因风险评分(PRS)。

主要发现

  • 38-SNP PRS可有效识别放射性脑损伤高风险个体(P=1.42×10⁻³⁴)。
  • 基于遗传风险计算,颞叶推荐耐受剂量为PRS前10%亚组57.6 Gy、PRS后50%亚组68.1 Gy。
  • 高遗传风险(PRS>P50)且颞叶接受高辐射剂量(D0.5CC>65 Gy)的个体,其风险约为低PRS且接受低辐射剂量个体的50倍(HR=50.09,95%CI=24.27-103.35),呈现相加联合效应(Pinteraction<0.001)。
  • 将PRS与年龄、肿瘤分期、颞叶辐射剂量等临床因素结合,预测准确性显著提高,C指数从0.78升至0.85(P=1.63×10⁻²)。

关键数值与推荐

  • PRS前10%亚组颞叶推荐耐受剂量为57.6 Gy。
  • PRS后50%亚组颞叶推荐耐受剂量为68.1 Gy。
  • 高遗传风险(PRS>P50)且颞叶D0.5CC>65 Gy者相比低PRS且低辐射剂量者HR=50.09(95%CI=24.27-103.35)。
  • PRS联合临床因素预测放射性脑损伤的C指数为0.85,高于未联合时的0.78(P=1.63×10⁻²)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiation-induced brain injury (RBI) is a severe radiotoxicity for nasopharyngeal carcinoma (NPC) patients, greatly affecting their long-term life quality and survival. We aim to establish a comprehensive predictive model including clinical factors and newly developed genetic variants to improve the precision of RBI risk stratification. MATERIALS AND METHODS: By performing a large registry-based retrospective study with magnetic resonance imaging follow-up on RBI development, we conducted a genome-wide association study and developed a polygenic risk score (PRS) for RBI in 1189 NPC patients who underwent intensity-modulated radiotherapy. We proposed a tolerance dose scheme for temporal lobe radiation based on the risk predicted by PRS. Additionally, we established a nomogram by combining PRS and clinical factors for RBI risk prediction. RESULTS: The 38-SNP PRS could effectively identify high-risk individuals of RBI (P = 1.42 × 10-34). Based on genetic risk calculation, the recommended tolerance doses of temporal lobes should be 57.6 Gy for individuals in the top 10 % PRS subgroup and 68.1 Gy for individuals in the bottom 50 % PRS. Notably, individuals with high genetic risk (PRS > P50) and receiving high radiation dose in the temporal lobes (D0.5CC > 65 Gy) had an approximate 50-fold risk over individuals with low PRS and receiving low radiation dose (HR = 50.09, 95 %CI = 24.27-103.35), showing an additive joint effect (Pinteraction < 0.001). By combining PRS with clinical factors including age, tumor stage, and radiation dose of temporal lobes, the predictive accuracy was significantly improved with C-index increased from 0.78 to 0.85 (P = 1.63 × 10-2). CONCLUSIONS: The PRS, together with clinical factors, could improve RBI risk stratification and implies personalized radiotherapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. He YQ, Wang TM, Yang DW, et al. A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma. Radiother Oncol. 2023. PMID: 37913956. doi:10.1016/j.radonc.2023.109974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。